Report Code: A14918 | Pages: NA | Mar 2023 | 640 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Papaverine Market
Request Now !Papaverine is a smooth muscle relaxant, which is used for the treatment of cerebral as well as peripheral ischemia conditions. These conditions are secondary to arterial spasm, which includes vascular spasm associated with acute myocardial infarction, medical & pulmonary embolism, peripheral vascular disease with vasospastic element, and angina pectoris. Papaverine are used to facilitate dilation of cerebral vessels before balloon angioplasty to treat non-occlusive mesenteric ischemia. It is further known to prevent spinal cord neurological injury in patients undergoing thoracoabdominal.
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years |  2021–2030 |
 Base Year Considered |  2020 |
 Forecast Period |  2021–2030 |
 Forecast Unit |  Value (USD) |
 Segments Covered |  Type, Application, Distribution Channel, and Region |
Â
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the papaverine market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In 2019, American Regent Inc., a developer, manufacturer, and supplier of high quality sterile injectables for healthcare providers, launched papaverine HCL, an injection that targets muscle spasm.
Key Benefits of the Report
Questions Answered in the Papaverine Market Report
Papaverine Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Sandoz,, American Regen, Chengdu Brilliant Pharmaceutical Group, Jiangsu Hengrui Medicine |
Loading Table Of Content...
Start reading.
This Report and over 19,651+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers